Skip to main content
Category

Cancer Epigenetics

Bioimaging Research and Innovation for Translational Engingeering BRITECancerCancer EpigeneticsCancer ProgramCell SignallingLabMesotheliomaNews & EventsResearch

Researchers discover blood markers that could predict mesothelioma treatment success

By | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer Epigenetics, Cancer Program, Cell Signalling, Lab, Mesothelioma, News & Events, Research

A groundbreaking study by researchers at the National Centre for Asbestos Related Diseases (NCARD), The Kids Research Institute and the Harry Perkins Institute of Medical Research (the Perkins) has identified…

Breast CancerBreast CancerCancerCancerCancer EpigeneticsCardiovascular DiseaseCardiovascular DiseaseEpigenetics and Genomics LaboratoryFundingGenome Biology and Genetic DiseasesMedia ReleasesMitochondrial diseaseMitochondrial DiseaseMitochondrial Medicine and BiologyNews & EventsResearchTranslation

WA researchers excel in nationally competitive grants

By | Breast Cancer, Breast Cancer, Cancer, Cancer, Cancer Epigenetics, Cardiovascular Disease, Cardiovascular Disease, Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Media Releases, Mitochondrial disease, Mitochondrial Disease, Mitochondrial Medicine and Biology, News & Events, Research, Translation

Eight (8) Federal government grants awarded to the Harry Perkins Institute of Medical Research Two of Australia’s most significant research grants, given only to the nation’s highest performing researchers, have…

CancerCancerCancer EpigeneticsDisease AreaEpigenetics and Genomics LaboratoryLabLiverLiver CancerLiver CancerLiver DiseaseMitochondrial Medicine and BiologyNews & EventsResearch

New discovery for treatment of primary liver cancer shows promise

By | Cancer, Cancer, Cancer Epigenetics, Disease Area, Epigenetics and Genomics Laboratory, Lab, Liver, Liver Cancer, Liver Cancer, Liver Disease, Mitochondrial Medicine and Biology, News & Events, Research

A study using preclinical models has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer…

Bioimaging Research and Innovation for Translational Engingeering BRITECancerCancerCancer EpigeneticsCell SignallingCell-To-Cell CommunicationFunctional GenomicsGenesMedia ReleasesNews & EventsSingle Cell

New liver cancer blood test gets $2.5m research funding boost

By | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer, Cancer Epigenetics, Cell Signalling, Cell-To-Cell Communication, Functional Genomics, Genes, Media Releases, News & Events, Single Cell

Predicting relapse for one of the world's deadliest cancers. Perth cancer researchers are on track to improve the outcomes of patients with the most common type of primary liver cancer.…

Bioimaging Research and Innovation for Translational Engingeering BRITECancerCancerCancer EpigeneticsCell SignallingCell-To-Cell CommunicationFunctional GenomicsGenesMedia ReleasesNews & EventsSingle Cell

ACRF Centre for Advanced Cancer Genomics opens in Perth

By | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer, Cancer Epigenetics, Cell Signalling, Cell-To-Cell Communication, Functional Genomics, Genes, Media Releases, News & Events, Single Cell

Latest technology analyses WA cancer patient tumours. The Australian Cancer Research Foundation (ACRF) Centre for Advanced Cancer Genomics, housing the next generation DNA sequencing technology, was opened today at the…

awardsCancerCancerCancer EpigeneticsCentre for Diabetes ResearchDiabetesDiabetesFundingInspirationLiverLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsTranslational Oncology

Perkins secures biobanking grants to answer important questions in future research

By | awards, Cancer, Cancer, Cancer Epigenetics, Centre for Diabetes Research, Diabetes, Diabetes, Funding, Inspiration, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Translational Oncology

The McGowan Government recently announced that the Harry Perkins Institute will receive two of the 16 grants totalling more than $1.5 million to support Western Australian biobanks. Congratulations to both…